Kingsview Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66M Buy
36,980
+973
+3% +$75K 0.04% 454
2025
Q4
$2.86M Sell
36,007
-68,425
-66% -$5.39M 0.04% 403
2025
Q3
$7.87M Buy
104,432
+79,340
+316% +$5.44M 0.12% 178
2025
Q2
$1.73M Sell
25,092
-2,209
-8% -$145K 0.03% 460
2025
Q1
$1.85M Sell
27,301
-157,333
-85% -$9.42M 0.03% 405
2024
Q4
$8.29M Buy
184,634
+15,400
+9% +$864K 0.16% 140
2024
Q3
$10.6M Buy
169,234
+3,105
+2% +$181K 0.22% 86
2024
Q2
$9.81M Buy
166,129
+29,685
+22% +$1.86M 0.23% 88
2024
Q1
$10.9M Buy
136,444
+7,088
+5% +$541K 0.27% 74
2023
Q4
$10.2M Buy
129,356
+99,128
+328% +$7.06M 0.31% 71
2023
Q3
$2.11M Sell
30,228
-3,296
-10% -$234K 0.08% 272
2023
Q2
$2.32M Sell
33,524
-3,892
-10% -$277K 0.09% 224
2023
Q1
$2.78M Sell
37,416
-2,193
-6% -$184K 0.12% 188
2022
Q4
$3.69M Sell
39,609
-304
-0.8% -$29.3K 0.16% 148
2022
Q3
$3.81M Buy
39,913
+1,728
+5% +$171K 0.18% 132
2022
Q2
$3.54M Sell
38,185
-10,187
-21% -$994K 0.17% 136
2022
Q1
$4.9M Buy
48,372
+13,445
+38% +$1.41M 0.22% 109
2021
Q4
$3.6M Buy
34,927
+3,722
+12% +$344K 0.15% 151
2021
Q3
$2.65M Buy
31,205
+1,449
+5% +$121K 0.13% 180
2021
Q2
$2.45M Buy
29,756
+1,587
+6% +$130K 0.12% 184
2021
Q1
$2.09M Sell
28,169
-9,441
-25% -$688K 0.12% 186
2020
Q4
$2.57M Buy
37,610
+10,019
+36% +$652K 0.19% 126
2020
Q3
$1.61M Sell
27,591
-838
-3% -$52.1K 0.14% 155
2020
Q2
$1.85M Sell
28,429
-453
-2% -$28.5K 0.18% 135
2020
Q1
$1.71M Buy
28,882
+13,105
+83% +$875K 0.23% 114
2019
Q4
$1.17M Buy
15,777
+3,957
+33% +$278K 0.15% 176
2019
Q3
$745K Buy
11,820
+92
+0.8% +$5.45K 0.12% 188
2019
Q2
$639K Sell
11,728
-134
-1% -$7.22K 0.11% 203
2019
Q1
$640K Buy
11,862
+5,713
+93% +$353K 0.1% 230
2018
Q4
$403K Sell
6,149
-1,684
-21% -$126K 0.09% 239
2018
Q3
$617K Buy
7,833
+3,522
+82% +$252K 0.13% 205
2018
Q2
$277K Sell
4,311
-307
-7% -$20.2K 0.07% 272
2018
Q1
$287K Sell
4,618
-411
-8% -$29.5K 0.07% 261
2017
Q4
$365K Buy
5,029
+810
+19% +$58.9K 0.13% 215
2017
Q3
$343K Sell
4,219
-3,548
-46% -$281K 0.15% 193
2017
Q2
$625K Buy
7,767
+244
+3% +$19.3K 0.32% 102
2017
Q1
$590K Buy
+7,523
New +$601K 0.35% 101

Other funds holding CVS

Kingsview Wealth Management's CVS Position: Q1 2026 in Review

Kingsview Wealth Management increased its CVS Health (CVS) stake by 2.7% in Q1 2026, buying an estimated $75K and bringing the position to 36,980 shares worth $2.66M. The position accounts for 0.04% of the portfolio, ranked #454.

Kingsview Wealth Management first reported a position in CVS in Q1 2017 and has held it in 37 quarters since. The position peaked at $10.9M in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Kingsview Wealth Management held 36,980 shares of CVS Health worth $2.66M as of Q1 2026.
  • Kingsview Wealth Management bought 973 CVS Health shares in Q1 2026, an estimated $75K.
  • CVS Health made up 0.04% of Kingsview Wealth Management's portfolio in Q1 2026, its #454 holding.
  • Kingsview Wealth Management first reported a position in CVS Health in Q1 2017 and has held it in 37 quarters since.
  • Kingsview Wealth Management's CVS Health position peaked at $10.9M in Q1 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.